about
Importance of pH homeostasis in metabolic health and diseases: crucial role of membrane proton transportRoles of interstitial fluid pH in diabetes mellitus: Glycolysis and mitochondrial functionEndoscopic and histologic findings in a cohort of uric acid and calcium oxalate stone formersThe Effect of Glycemic Status on Kidney Stone Disease in Patients with Prediabetes.Uric Acid Nephrolithiasis: A Systemic Metabolic Disorder.Comparison of Nephrolithiasis Prevalence in Two Bottlenose Dolphin (Tursiops truncatus) Populations.Perirenal fat thickness measured with computed tomography is a reliable estimate of perirenal fat mass.Influence of a home-based exercise program on the urine pH in elderly female subjects: a secondary analysis of a randomized controlled trialAssessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.Lactobacillus casei reduces susceptibility to type 2 diabetes via microbiota-mediated body chloride ion influx.Established dietary estimates of net acid production do not predict measured net acid excretion in patients with Type 2 diabetes on Paleolithic-Hunter-Gatherer-type dietsUse of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.Lower urinary pH is useful for predicting renovascular disorder onset in patients with diabetes.The Vacuolar H+-ATPase B1 Subunit Polymorphism p.E161K Associates with Impaired Urinary Acidification in Recurrent Stone Formers.The diurnal variation in urine acidification differs between normal individuals and uric acid stone formersMetabolic syndrome and the risk of calcium stones.Epidemiology and clinical pathophysiology of uric acid kidney stones.Dietary and lifestyle factors and medical conditions associated with urinary citrate excretionSulfatides are required for renal adaptation to chronic metabolic acidosis.Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.Body fat content and distribution and urinary risk factors for nephrolithiasis.Is oxidative stress, a link between nephrolithiasis and obesity, hypertension, diabetes, chronic kidney disease, metabolic syndrome?Urinary pH reflects dietary acid load in patients with type 2 diabetesRole of Acid-Base Homeostasis in Diabetic Kidney Disease.Higher net acid excretion is associated with a lower risk of kidney disease progression in patients with diabetes.The Relationship Between Nephrolithiasis Risk with Body Fat Measured by Body Composition Analyzer in Obese People.Association of urinary citrate excretion, pH, and net gastrointestinal alkali absorption with diet, diuretic use, and blood glucose concentration.Nephrolithiasis: nutrition as cause or therapeutic tool.Urine alkalization improves the problems of pain and sleep in hypersensitive bladder syndrome.Latent association between low urine pH and low body weight in an apparently healthy population.Determinants of calcium and oxalate excretion in subjects with calcium nephrolithiasis: the role of metabolic syndrome traits.Metabolic Acidosis or Respiratory Alkalosis? Evaluation of a Low Plasma Bicarbonate Using the Urine Anion Gap.Insulin Sensitivity and Glucose Homeostasis Can Be Influenced by Metabolic Acid Load.Improving sample classification by harnessing the potential of H-NMR signal chemical shifts
P2860
Q26995687-922BF326-BC9E-4A3D-9C4B-846CBC8067AFQ27013026-B4879C80-B482-4448-8046-723AEC2B4289Q27303089-84DF1C22-CCD4-494B-B75E-974363A83AEAQ30384110-A0990A95-B39E-4AB1-889E-373D37B4BD12Q30434757-1FDA4C07-A610-4338-956E-D47C51B123D5Q30448251-8C418734-1D17-46FB-8BD1-F6595ECC9F70Q33579577-935C0BA0-14AF-42F1-B70C-F62E1CC05115Q33696805-B845A72D-4A63-489D-AC83-97337EA180B0Q33912524-4B339D02-179C-45DA-93F3-791B4078564BQ34057023-4B0B3C9B-9A2F-49C7-BC43-1ECE5CA80BF6Q34407250-BBC35F38-384A-4141-A445-F416E2CDFCE4Q34487788-7792B282-C570-4255-B53C-0CA79E57F178Q34580630-A498086D-1C60-4FD2-A85B-F5ED79A7C32DQ35802311-43A1EB2A-D043-439C-8FFB-071BB33DAC93Q35802404-7C2C8BD7-3D8E-4473-9156-F1CB9CD5923CQ35962409-F011C3E9-508A-4E37-B0F2-E7BF0CC30A50Q36129839-415C1FBF-A16A-455F-989A-BCAEBC8FEE7BQ36417612-850454A7-5AD1-4133-AC5F-BE67CB59C638Q36910910-DB380A3F-C6E2-4E5E-B906-957E3A06BA8DQ36932483-3F850BB3-FE15-41D5-843F-2E827F12D237Q37342136-ACC8817C-7976-4A86-8D1F-7097B7AA5565Q37426986-82AE36AA-E001-4558-9D67-CCCE142ED117Q37972817-56FB8073-8ED7-4AA8-891F-5C09998EF85AQ38656378-1E4C4AF9-0ABE-4503-8974-A16288579076Q38875980-C6B69FC4-269A-44EB-9E11-3137864B9910Q40443306-1B706F2E-6101-4AA7-85A7-688D751CA454Q41257861-003E3806-CF96-40DD-B420-8B3A347FED12Q42378090-A287627B-38F9-4BDC-9DAF-5AC70A5067C5Q43066311-BD8A61D2-4CB7-4E2C-B5C6-628A97D9C32FQ44957378-5DCD7071-7050-4C4C-B087-FA99F009A591Q47354923-86D06363-9661-4BFA-8A9B-349592C2A26DQ47678841-2C93A07F-85ED-42D5-8D14-20057B851D0FQ47867197-54B15D76-A815-4B96-A500-479BF609A189Q55316993-3955B81C-9308-4A4D-B288-0B7EB48D0E22Q57015972-0B075D2C-D855-469C-BBB2-EEDE6B587EEC
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Metabolic basis for low urine pH in type 2 diabetes.
@ast
Metabolic basis for low urine pH in type 2 diabetes.
@en
type
label
Metabolic basis for low urine pH in type 2 diabetes.
@ast
Metabolic basis for low urine pH in type 2 diabetes.
@en
prefLabel
Metabolic basis for low urine pH in type 2 diabetes.
@ast
Metabolic basis for low urine pH in type 2 diabetes.
@en
P2093
P2860
P356
P1476
Metabolic basis for low urine pH in type 2 diabetes.
@en
P2093
Khashayar Sakhaee
Mary Ann Cameron
Naim M Maalouf
Orson W Moe
P2860
P304
P356
10.2215/CJN.08331109
P577
2010-04-22T00:00:00Z